PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 27.612
EU - Europa 22.774
AS - Asia 15.740
SA - Sud America 1.862
AF - Africa 312
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 20
Totale 68.363
Nazione #
US - Stati Uniti d'America 27.245
RU - Federazione Russa 6.975
SG - Singapore 6.683
GB - Regno Unito 6.273
CN - Cina 4.917
IT - Italia 2.150
BR - Brasile 1.528
SE - Svezia 1.517
DE - Germania 1.312
FR - Francia 1.261
HK - Hong Kong 1.163
VN - Vietnam 1.127
FI - Finlandia 1.123
IE - Irlanda 1.113
KR - Corea 519
UA - Ucraina 420
IN - India 220
JP - Giappone 193
CA - Canada 191
BD - Bangladesh 186
TR - Turchia 160
AR - Argentina 123
BE - Belgio 121
MX - Messico 104
NL - Olanda 94
NG - Nigeria 84
ID - Indonesia 81
PL - Polonia 79
IQ - Iraq 77
ES - Italia 75
ZA - Sudafrica 74
IR - Iran 62
PK - Pakistan 58
EC - Ecuador 54
UZ - Uzbekistan 39
VE - Venezuela 37
AU - Australia 33
MA - Marocco 33
CO - Colombia 31
CZ - Repubblica Ceca 31
PY - Paraguay 28
RO - Romania 27
CH - Svizzera 26
LT - Lituania 26
AT - Austria 25
AE - Emirati Arabi Uniti 23
AZ - Azerbaigian 21
CL - Cile 20
EG - Egitto 20
SA - Arabia Saudita 20
KE - Kenya 19
PE - Perù 19
NP - Nepal 18
PH - Filippine 18
IL - Israele 17
MY - Malesia 17
BG - Bulgaria 16
KG - Kirghizistan 14
TN - Tunisia 14
BO - Bolivia 13
DZ - Algeria 13
EU - Europa 13
JO - Giordania 13
PA - Panama 13
AL - Albania 12
LB - Libano 11
RS - Serbia 11
KZ - Kazakistan 10
CR - Costa Rica 9
JM - Giamaica 9
LV - Lettonia 9
NZ - Nuova Zelanda 9
SN - Senegal 9
TT - Trinidad e Tobago 9
HU - Ungheria 8
PS - Palestinian Territory 8
PT - Portogallo 8
DK - Danimarca 7
HR - Croazia 7
OM - Oman 7
SY - Repubblica araba siriana 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
SK - Slovacchia (Repubblica Slovacca) 6
TG - Togo 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BH - Bahrain 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
GA - Gabon 5
HN - Honduras 5
KW - Kuwait 5
MD - Moldavia 5
NO - Norvegia 5
AM - Armenia 4
BJ - Benin 4
CY - Cipro 4
EE - Estonia 4
Totale 68.266
Città #
Southend 5.299
Jacksonville 3.689
Singapore 3.679
Ashburn 3.013
Chandler 2.484
Dallas 2.387
Moscow 2.162
Woodbridge 2.116
San Jose 2.038
Ann Arbor 1.394
Houston 1.203
Hong Kong 1.141
Dublin 1.111
The Dalles 748
Verona 657
Beijing 634
Wilmington 472
Lawrence 445
Princeton 445
Jinan 444
Los Angeles 443
Nanjing 413
New York 413
Ho Chi Minh City 368
Shenyang 353
Council Bluffs 349
Buffalo 279
Hanoi 264
Hebei 229
Helsinki 211
Tianjin 210
Boardman 202
Sindelfingen 185
Munich 179
Columbus 156
Milan 155
Changsha 154
Zhengzhou 153
São Paulo 151
Nanchang 142
Santa Clara 137
Haikou 131
Hangzhou 127
Ningbo 124
Brussels 113
Taizhou 113
Tokyo 112
Jiaxing 107
Orem 103
Guangzhou 99
Seattle 97
Philadelphia 90
Redondo Beach 86
Taiyuan 86
Washington 82
Turku 79
Falls Church 75
Seoul 74
London 73
Frankfurt am Main 72
Norwalk 71
Abuja 70
Rome 70
Lancaster 68
Montreal 66
San Francisco 66
Chennai 63
Warsaw 60
Toronto 58
Chicago 57
Dearborn 57
Fuzhou 57
Auburn Hills 56
Brooklyn 56
Denver 53
Düsseldorf 51
Stockholm 51
Redmond 49
Rio de Janeiro 48
Fairfield 47
Manchester 47
Da Nang 46
Lanzhou 46
Amsterdam 44
Jakarta 44
Haiphong 43
Atlanta 42
Boston 41
Johannesburg 37
Phoenix 37
Mumbai 34
Tashkent 33
Paris 31
Bologna 30
Dong Ket 30
Biên Hòa 29
Brasília 29
Cambridge 29
Madrid 29
Shanghai 29
Totale 44.454
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 472
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 441
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 436
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 322
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 311
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 306
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 295
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 294
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 294
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 277
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 269
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 267
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 266
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 266
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 262
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 259
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 256
A rapid immunostaining method for frozen sections 253
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 249
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 249
A study of the crosstalk between CD30 and CXCR4 248
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 246
Acute leukemia and pregnancy. Case report 245
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 244
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 243
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 241
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 241
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 241
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 240
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 240
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 237
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 237
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 237
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 236
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 235
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 233
BCR-signaling profiles associated with prognosis and progression in B-CLL 232
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 232
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 230
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 230
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 229
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 228
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 227
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 227
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 226
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
Blastic OKT6-positive proliferation preceding malignant histiocytosis 222
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 221
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 220
BCR-signaling profiles associated with prognosis and progression in B-CLL 220
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 220
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 219
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 219
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 216
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 215
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 215
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 212
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 211
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 211
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 211
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 211
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 210
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 209
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 208
[Haemolytic anaemia associated with acquired deficiency of erythrocyte glutathione peroxidase: use of sodium selenite to correct the enzyme defect (author's transl)] 207
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 207
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 206
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 206
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 205
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 205
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 203
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 202
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 202
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 201
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 201
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 201
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 201
[Immunology of the lymphatic follicle] 200
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 200
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 200
An unusual case of acute leukaemia 199
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 199
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 199
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 199
G-CSF-stimulated neutrophils are a prominent source of functional B-lymphocyte stimulator (BLyS) 199
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 198
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 197
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 196
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 195
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 195
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 192
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 192
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 191
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations 191
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 191
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function 191
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 191
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 189
Biological prognostic factors in indolent lymphoma 189
Totale 23.198
Categoria #
all - tutte 208.905
article - articoli 150.265
book - libri 0
conference - conferenze 55.960
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.680
Totale 417.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 0 0 203
2021/20223.812 331 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20258.611 600 595 220 1.458 472 279 318 383 1.323 475 706 1.782
2025/202624.173 1.866 1.831 1.905 3.535 5.636 1.730 2.436 1.257 1.776 1.372 396 433
Totale 68.678